H&F Corporate Investors X, Ltd., a registered investment adviser, initiated a new position in Medline Inc. (NASDAQ GLOBAL SELECT:MDLN) during Q4 2025, according to its most recent 13F filing with the Securities and Exchange Commission.
The institutional investor purchased 99,514,069 shares of the company, valued at approximately $4.2B as of the filing date.
Medline Inc.'s stock currently trades at $47.76.